Undetectable Isn’t the Whole Story: Study Finds Signs of HIV Immune Activity in the Brain
By Michael Gwarisa For millions of people living with HIV, achieving an undetectable viral load is the ultimate treatment milestone, a sign that antiretroviral therapy is working and that the virus is under control. But scientists are increasingly discovering that what happens in the blood may not tell the whole story. New research unveiled during
Read More
Once-Weekly HIV Pill Matches Daily Treatment in Landmark Phase III Trials Ahead of AIDS 2026
By Michael Gwarisa A once-weekly pill for HIV treatment has performed as well as standard daily therapy in two landmark Phase III clinical trials, bringing researchers a step closer to offering people living with HIV the world’s first complete once-weekly oral treatment regimen. The findings from the ISLEND-1 and ISLEND-2 studies will be presented at
Read More
Japanese Study Identifies Genetic Mismatch That Triples Risk of Life-Threatening Complications After Cord Blood Transplant
Michael Gwarisa More than 7,400 patients in Japan have contributed to a breakthrough study identifying a hidden genetic mismatch that significantly increases the risk of life-threatening immune complications after umbilical cord blood transplantation. The research, led by Associate Professor Takakazu Kawase of Fujita Health University and the Japanese Society for Transplantation and Cellular Therapy (JSTCT)
Read More
Restless leg syndrome may increase Parkinson’s disease risk, study finds
According to the National Institute of Neurological Disorders and StrokeTrusted Source, restless leg syndrome “is a neurological condition that causes an irresistible urge to move the legs.” The condition impacts 7-10%Trusted Source of people in the U.S. The relationship between Parkinson’s disease and restless leg syndrome is an area of ongoing research. A study recently published in JAMA Network OpenTrusted Source found
Read More